Posts Tagged ‘heb’

Hemispherx BioPharma, Inc (AMEX: HEB) Surges after FDA Lifted Phase II Alferon LDO Clinical Study

Tuesday, January 4th, 2011

Hemispherx BioPharma, Inc (AMEX:HEB) went up by 5.73% and is currently trading at $0.519 after opening at $0.49 with volume of 4.09 million shares traded after the Food and Drug Administration (FDA) authorizes Alferon(R) LDO clinical Phase II trial for the prevention and treatment of influenza.

The FDA noted that the company had completed the review of a submission dated November 12, 2010 which provided a Complete Response to the Agency’s reasons for continuing this study on clinical hold.

On Dec 28, The Company announced its intention to restate its financial statements in its Annual Report on Form 10-K for the year ended December 31, 2009 and in its Forms 10-Q for the periods ended March 31, 2010, June 30, 2010 and September 30, 2010 (including the comparable periods ended June 30, 2009 and September 30, 2009).

The Company announced on Dec 20 that it had entered into an agreement with GP Pharm Latinoamerica for the marketing of Alferon N Injection®, which is the company’s natural interferon injection approved by the FDA for a category of sexually transmitted diseases in Argentina.  As per the agreement, the company will manufacture and supply the injections to GP Pharm in Argentina. Meanwhile, GP Pharm will have the responsibility of obtaining regulatory approval for each indication and commercialization of Alferon N Injection in Argentina.

Shares of a Philadelphia-based specialty pharmaceutical company traded in the range of $0.49-$0.61. The Stock has 52 week range of $0.44-$0.87. Currently, the market capitalization of the stock stands at $71.58 million with beta of 1.11. The Stock has 50 day & 200 day moving average of $0.50 & $0.51 respectively. The Company has total outstanding shares of 135.24 million, of which 131.10 million shares are floating.

Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company focuses on two core pharmaceutical technology platforms Ampligen and Alferon N Injection.

Tags: , , ,
Posted in Small Cap Stocks, Stocks | No Comments »

DJIA, S&P Set to Hit New 52 Week High!!!

Friday, March 12th, 2010

Markets are set to hit a new 52 week high, in thanks to encouraging retail sales. In fact, we could see these highs taken out today, with SPX futures trading nearly 3 points above fair value, and DJIA futures more than 84 points above fair value. What’s more, a sharp rally on Wall Street could send the CBOE Market Volatility Index (VIX) to a fresh multi-year low. The VIX is currently hovering just above the 18 level, and is slightly more than a point away from its lowest levels since May 19, 2008.

Asian stocks closed mixed as China is struggling to strike a monetary policy balance, while European shares were higher as production data from the euro zone showed the region may be in for a stronger-than-expected recovery.

Currency News

Markets are also exuberant because it’s been rumored that China might be forced to inflate the Yuan. US is said to have substantiating facts that China has been manipulating the Yuan, artificially pegged to the dollar. US has threatened to place trade sanctions if actions are not made soon.

The Canadian Dollar just touched a 40 week high of 1.0263. I expect to see parity within the next few months.

The Australian Dollar currently trades $ .91. The Australians have been raising their Fed Fund rates since early 2009. The Ausi $ has appreciated 51% against the dollar within 1 year.

The Euro currently trades $1.3783. It has tumbled 9.27% since Greece announced the austerity measures.

Tags: , , , , , , , ,
Posted in Contributors, Economics, Stock Market News | No Comments »

Stocks Rally 30 Minutes Towards Close

Thursday, March 11th, 2010

The stock market started the morning weak, dropping 50 points within the first hour of the trading session. By 11 AM EST, US equities bounced on both sides of the water  +/- break-even. I like to use the Ping Pong analogy as markets experienced throughout the major part of the day. It was pretty boring, that is until 3:25 PM. Buy orders were filling in quick. Shorts were forced to cover.

There hasn’t been much news to contribute to the market’s slide or climb.  

Highlight of the major headlines below:

Financial Reform remains on Gridlock

Initial jobless claims fell by 6,000  last week; economists had expected claims to drop by 8,000. I think numbers are inclined for the worst, especially with the news released today joining California and Kansas; New York and New Jersey. They have announced that significant cuts will be expected in Health Care and Education. More cuts in teachers jobs. Very disheartening.

Separate reports showed the trade gap shrank 6.6 percent as oil imports dropped to their lowest level since February 1999, and mortgage rates dropped for a second straight week, remaining below 5 percent.

30-year bond auction was met with solid demand: The high yield was 4.679 percent and the bid-to-cover ratio was 2.89.

A report out of China showed inflation rose to a six-month high, escalating fears that the economy is overheating and demand for commodities and other goods may start to slow.

Canada is also looking to raise inflation to an annual average of a tepid 2% to steer away from deflation.

In Greece, strikes against austerity measures all but paralyzed the country, grounding flights and closing schools.

Treasury Secretary Tim Geithner wrote a note to European regulatory officials, warning them not to tighten rules on hedge funds and private-equity companies as this would discriminate against U.S. entities, the Financial Times reported.

In stocks

Palm:Continues to take a beating, closing at $5.25. We made the initial call at $9.09 prior to the rating agencies downgrade. Gain from Short: 27% gain

DDR: Continues it’s upward push! Amazing as I had called it to break it’s 52 week high day after day. Up 17%

C: Best “bad bank” on the market. Highly undervalued as I anticipate Citigroup to break it’s 52 week high and close the year around $6. Hedge funds have been gobbling up shares as trading volume climbs.

Speculative Stock – (Short Term Gain)

HEB:$ .82 Huge momentum, trading on the AMEX.  Short squeeze of $12million 9.9% short float. Momentum approaching 100 moving average. +20% potential gain.

Cheers!!!

Tags: , , , , ,
Posted in Contributors, Debt, Economics, Small Cap Stocks, Stock Market News, Technical Stocks | No Comments »